Vivent is an electroceuticals company that uses biosignals to develop medical solutions and monitoring technologies for plant health.
Vivent has raised €2.3M across 2 funding rounds from 3 investors, most recently a Debt round in Jan 2022. Based in Gland, Switzerland; active in Agritech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-01-31 | Debt | €481k | Foundation for Technological Innovation (FIT) | View deal → |
| 2021-11-29 | Other | €1.8M | Astanor Ventures,ePlant | View deal → |
